Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOTRON LIMITED Director's Dealing 2022

Nov 28, 2022

64528_rns_2022-11-28_7e1a73f5-fae8-4eb2-a5bf-00b85a91e260.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [229 x 36] intentionally omitted <==

Level 2, 66 Hunter Street Sydney NSW 2000 Tel: (61-2) 9300 3344 Fax: (61-2) 9221 6333 E-mail: [email protected] Website: www.biotron.com.au

29 November 2022

The Manager Companies ASX Limited 20 Bridge Street SYDNEY NSW 2000

(9 pages by email)

Dear Madam,

DIRECTORS’ INTERESTS

In accordance with Listing Rule 3.19A, I attach Appendix 3Y, Change of Director's Interest Notice, for Michael J. Hoy, Michelle Miller, Susan Pond and Robert Thomas.

This announcement has been approved by the Managing Director, Michelle Miller.

Yours sincerely

==> picture [91 x 60] intentionally omitted <==

Peter J. Nightingale Company Secretary

pjn11482

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity BIOTRON LIMITED
ABN 60 086 399 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Michael J. HOY
Date of last notice 7 November 2019.

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect.
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevantinterest.
Umbiram Pty Limited A/C> in which Michael Hoy has a beneficial interest.
Date of change 25 November 2022.
No. of securities held prior to change 9,347,793 fully paid ordinary shares held by
Umbiram Pty Limited A/C>.
Class Fully paid ordinary shares.
25 November 2024, 6 cent listed options.
Number acquired 1,869,559 fully paid ordinary shares acquired on 25
November 2022 under a rights issue and 934,780
attached listed options.
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation.
Shares at $0.03 each and Listed Options at $0.
No. of securities held after change 11,217,352 fully paid ordinary and 934,780 listed
options held by Umbiram Pty Limited Superfund A/C>.
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation
in buy-back.
Acquisition under a rights issue.
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil.
Nature of interest N/A.
Name of registered holder
(if issued securities)
N/A.
Date of change N/A.
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to which
the interest has changed.
N/A.
Interest acquired N/A.
Interest disposed N/A.
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation.
N/A.
Interest after change N/A.

Part 3 –[+] Closed period

Were the interests in the securities or
contracts detailed above traded during
a+closed period where prior written
clearance was required?
No.
If so, was prior written clearance
provided to allow the trade to proceed
during this period?
N/A.
If prior written clearance was provided,
on what date was thisprovided?
N/A.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity BIOTRON LIMITED
ABN 60 086 399 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Susan Pond
Date of last notice 10 December 2019.

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect.
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
BT Portfolio Services Limited A/C> in which Susan Pond has a beneficial interest.
Date of change 25 November 2022.
No. of securities held prior to change 654,295 fully paid ordinary shares held BT Portfolio
Services Limited
Class Fully paid ordinary shares.
25 November 2024, 6 cent listed options.
Number acquired 130,859 fully paid ordinary shares acquired on 25
November 2022 under a rights issue and 65,430
attached listed options.
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation.
Shares at $0.03 each and Listed Options at $0.
No. of securities held after change 785,154 fully paid ordinary and 65,430 listed options
held by BT Portfolio Services Limited Effeney S/F A/C>
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back.
Acquisition under a rights issue.
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil.
Nature of interest N/A.
Name of registered holder
(if issued securities)
N/A.
Date of change N/A.
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to which
the interest has changed.
N/A.
Interest acquired N/A.
Interest disposed N/A.
Value/Consideration
Note: If consideration is non-cash, provide details and an estimated
valuation.
N/A.
Interest after change N/A.

Part 3 –[+] Closed period

Were the interests in the securities or
contracts detailed above traded during a
+closed period where prior written
clearance was required?
No.
If so, was prior written clearance
provided to allow the trade to proceed
during this period?
N/A.
If prior written clearance was provided,
on what date was thisprovided?
N/A.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity BIOTRON LIMITED
ABN 60 086 399 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Michelle Miller
Date of last notice 23 December 2019.

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect.
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to
the relevant interest.
Michelle Miller + Peter Clarke A/C> in which Michelle Miller has a beneficial interest.
Date of change 25 November 2022 and 26 November 2022
No. of securities held prior to change 1,656,250 fully paid ordinary shares held by Michelle Miller;
1,500,000 Michelle Miller + Peter Clarke Super Fund A/C>;
1,000,000 26 November 2022 20 cent options;
1,000,000 26 November 2023 20 cent options.
Class Fully paid ordinary shares.
25 November 2024, 6 cent listed options.
Number acquired 631,250 fully paid ordinary shares acquired on 25 November
2022 under a rights issue and 315,625 attached listed options.
Number disposed 1,000,000 26 November 2022 20 cent options (expired);
Value/Consideration
Note: If consideration is non-cash, provide details and
estimated valuation.
Shares acquired under the rights issue at $0.03 each and listed
Options at $0.
1,000,000 options expired unexercised $Nil
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 1,987,500 fully paid ordinary shares and 165,625 listed
options held by Michelle Miller;
1,800,000 fully paid ordinary shares and 150,000 listed
options held by Michelle Miller + Peter Clarke Super Fund A/C>;
1,000,000 26 November 2023, 20 cents options
Nature of change
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment
plan, participation in buy-back.
Acquisition under a rights issue.

\Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil.
Nature of interest N/A.
Name of registered holder
(if issued securities)
N/A.
Date of change N/A.
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in
relation to which the interest has changed.
N/A.
Interest acquired N/A.
Interest disposed N/A.
Value/Consideration
Note: If consideration is non-cash, provide details and
an estimated valuation.
N/A.
Interest after change N/A.

Part 3 –[+] Closed period

Were the interests in the
securities or contracts detailed
above traded during a+closed
period where prior written
clearance was required?
No.
If so, was prior written clearance
provided to allow the trade to
proceed during this period?
N/A.
If prior written clearance was
provided, on what date was this
provided?
N/A.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity BIOTRON LIMITED
ABN 60 086 399 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Robert B. Thomas
Date of last notice 22 January 2020.

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect.
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to
therelevantinterest.
Murtoa Flour Mills Pty Ltd in
which Robert Thomas has a benefial interest.
Date of change 25 November 2022.
No. of securities held prior to change 2,663,195 fully paid ordinary shares held by Murtoa Flour
Mills Pty Ltd
Class Fully paid ordinary shares.
25 November 2024, 6 cent listed options.
Number acquired 536,805 fully paid ordinary shares acquired on 25 November
2022 under a rights issue and 268,403 attached listed
options.
Number disposed Nil
Value/Consideration
Note: If consideration is non-cash, provide details and
estimated valuation.
Shares at $0.03 each and Options at $0.
No. of securities held after change 4,200,000 fully paid ordinary and 268,403 listed options
held by Murtoa Flour Mills Pty Ltd A/C>
Nature of change
Example: on-market trade, off-market trade, exercise of
options, issue of securities under dividend reinvestment
plan, participation in buy-back.
Acquisition under a rights issue.
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nil.
Nature of interest N/A.
Name of registered holder
(if issued securities)
N/A.
Date of change N/A.
No. and class of securities to
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed.
N/A.
Interest acquired N/A.
Interest disposed N/A.
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation.
N/A.
Interest after change N/A.

Part 3 –[+] Closed period

Were the interests in the securities
or contracts detailed above traded
during a+closed period where
prior written clearance was
required?
No.
If so, was prior written clearance
provided to allow the trade to
proceed during this period?
N/A.
If prior written clearance was
provided, on what date was this
provided?
N/A.
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011